Next-Gen Closed System Transfer Devices : Market Forecast, Transformation, and Long-Term Trajectories
Discover trends, market shifts, and competitive outlooks for the closed system transfer devices industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research
What is the Projected CAGR for the Closed System Transfer Devices Market Size from 2025 to 2034?
In recent times, there has been a significant growth in the market size of closed system transfer devices. This market is forecasted to expand from $1.04 billion in 2024 to $1.19 billion in 2025, indicating a compound annual growth rate (CAGR) of 14.5%. This growth during the historical period can be credited to the rise in approvals for oncology drugs, increasing emphasis on job safety, the urgent need to reduce needlestick injuries and exposure to dangerous drugs, enhanced consciousness about the potential risks associated with exposure to cytotoxic drugs, and a surge in the population of chemotherapy patients.
In the upcoming years, the market size of closed system transfer devices is anticipated to experience a fast growth. By 2029, it is estimated to rise to $2.03 billion, boasting a compound annual growth rate (CAGR) of 14.3%. Factors such as the escalating incidence of cancer, the mounting necessity for compliance monitoring for safe handling of harmful drugs, growing consciousness about the usage of closed system transfer devices, the increased adoption of CSTDS for handling risky medications, and a higher number of cancer drug sanctions can account for this expected growth. Future trends include the launch of new products and an emphasis on safety, the creation of user-friendly devices and digital platforms, high levels of research and development, advances in technology, and a shift towards membrane-to-membrane systems.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15767&type=smp
Which Major Market Drivers Are Expected to Boost the Growth Potential of the Closed System Transfer Devices Market?
As cancer rates continue to rise, the demand for closed-system transfer devices in the medical market is expected to increase, directly propelling its market growth. Notably, cancer, a condition distinguished by uncontrolled abnormal cell growth that infringes upon neighboring tissues and spreads throughout the body via the blood and lymph systems, is being increasingly observed. Triggers for such prevalence can include lifestyle choices, environmental influences, and a spike in infections. Closed-system transfer devices play a pivotal role in cancer treatment by acting as a protective barrier for both healthcare practitioners and patients against risks while dealing with chemotherapy drugs. Consequently, they promote a safer medical environment and enhance treatment outcomes for cancer patients. For instance, the World Health Organization, a Swiss-based international organization, predicts that by 2050, we can anticipate cancer instances to surpass 35 million, marking a 77% surge from the estimated 20 million cases forecasted for 2022. This stark increase only amplifies the growing global cancer burden. According to the National Center for Biotechnology Information, a US-based international organization, 1,958,310 new cancer cases and an expected 609,820 cancer-related deaths were reported in the US alone in 2023. Hence, the escalating number of cancer cases fuels the expansion of the closed system transfer devices market.
Which Key Market Segments Comprise the Closed System Transfer Devices Market and Drive Its Revenue Growth?
The closed system transfer devices market covered in this report is segmented –
1) By Type: Needleless Systems, Membrane-To-Membrane Systems
2) By Technology: Diaphragm-Based, Compartmentalized, Filtration
3) By Closing Mechanism: Color-To-Color Alignment Systems, Push-To-Turn Systems, Click-To-Lock Systems, Luer-Lock Systems
4) By End User: Hospitals And Clinics, Oncology Centers, Other End Users
Subsegments:
1) By Needleless Systems: Closed Vial Systems, Closed Syringe Systems, Transfer Device Adapters
2) By Membrane-To-Membrane Systems: Membrane-To-Membrane Transfer Devices, Filtered Membrane Transfer Devices
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=15767&type=smp
Which Areas Are Leading Regions in the Closed System Transfer Devices Market Expansion Across the Globe?
North America was the largest region in the closed system transfer device market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the closed system transfer devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
What Key Trends Are Shaping the Future of the Closed System Transfer Devices Market?
Leading firms in the closed system transfer devices (CSTD) market are prioritising the development of innovative syringe units to boost safety, augment user convenience, minimise contamination risk, and meet tight health industry regulations. A syringe developed for full volume use is one intended to deliver or administer the entirety of a fluid or drug, with no extra dilution or mixing required. For instance, in October 2023, the US-based medical equipment firm, Equashield, introduced the EQUASHIELD Syringe Unit, which secured FDA approval for full-volume usage, enabling safer and more effective handling of hazardous medications. This revolutionary design stops the escape of vapours and contamination of the plunger, making it an economical solution for compounding and administering drugs.
View the full report here:
How Is the Closed System Transfer Devices Market Conceptually Defined?
Closed system transfer devices (CSTDs) are specialized drug transfer devices designed to mechanically prevent environmental contaminants from entering the system and to stop hazardous drugs or vapor concentrations from escaping. These devices create a closed, leak-proof system to ensure the safe handling of hazardous substances in healthcare environments.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15767
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
